Private Equity firm slams Prochlorperazine decision

Counsel to a private equity group fined by the UK antitrust watchdog for its alleged part in the Prochlorperazine cartel has hit out at the agency, telling the Competition Appeal Tribunal that the enforcer showed a “troubling lack of restraint” in its sanctions decision.